Consistent with the previous report referring to M2 macrophages in NSCLC patients, a significant increase in CD163+PD-L1+ M2 macrophages and a decrease in CTLs and Th cells in HPD tissue were observed in the present study. Here, CD163 is linked to non-small cell lung carcinoma.